These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8761558)

  • 1. Serum lipids in black Africans on chronic ambulatory peritoneal dialysis.
    Abiola OO; Olubodun JO; Agbedana EO; Taylor GO
    Perit Dial Int; 1996; 16(3):333-4. PubMed ID: 8761558
    [No Abstract]   [Full Text] [Related]  

  • 2. Body composition and lipid abnormalities in hispanic and black patients on continuous ambulatory peritoneal dialysis.
    Henriquez MA; Gonzalez A; Bemis JA; Esquivel J
    Perit Dial Int; 1993; 13 Suppl 2():S424-7. PubMed ID: 8399630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins.
    Breckenridge WC; Roncari DA; Khanna R; Oreopoulos DG
    Atherosclerosis; 1982 Dec; 45(3):249-58. PubMed ID: 6961923
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid abnormalities in end stage renal disease.
    Oda H; Keane WF
    Nephrol Dial Transplant; 1998; 13 Suppl 1():45-9. PubMed ID: 9507498
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum myoglobin in patients on intermittent and continuous ambulatory peritoneal dialysis.
    Feinfeld DA; Verger C; Briscoe AM; Hotchkiss JL; Nurse HM; Merlin F; Nair S; Hart PM
    Clin Nephrol; 1987 Sep; 28(3):144-6. PubMed ID: 3665208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
    Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
    BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
    Radovanović Lj; Popović J; Radlović O
    Srp Arh Celok Lek; 1988; 116(11-12):967-76. PubMed ID: 3247614
    [No Abstract]   [Full Text] [Related]  

  • 9. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients.
    Fung L; Pollock CA; Caterson RJ; Mahony JF; Waugh DA; Macadam C; Ibels LS
    J Am Soc Nephrol; 1996 May; 7(5):737-44. PubMed ID: 8738809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of renal function in Black South African patients with malignant hypertension: superiority of continuous ambulatory peritoneal dialysis over hemodialysis.
    Katz IJ; Sofianou L; Butler O; Hopley M
    Perit Dial Int; 2001; 21(6):581-6. PubMed ID: 11783767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Takác M
    Vnitr Lek; 1982 Jun; 28(6):602-8. PubMed ID: 7112984
    [No Abstract]   [Full Text] [Related]  

  • 13. Low serum CA125 concentration in chronic renal failure treated with continuous ambulatory peritoneal dialysis.
    Kawabe T; Ishii M; Sugimoto T; Tagawa H
    Clin Chim Acta; 1987 Sep; 168(1):113-4. PubMed ID: 3478159
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitamins and continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Szabó T; Dandár V; Takác M
    Cas Lek Cesk; 1983 Aug; 122(34):1046-9. PubMed ID: 6627319
    [No Abstract]   [Full Text] [Related]  

  • 15. No need to measure serum aluminum in patients starting chronic ambulatory peritoneal dialysis.
    Musso CG; Bailey S; Shu M; Liakopoulos VC; Savaj S; Ghareeb S; Sahu K; Oreopoulos DG
    Perit Dial Int; 2002; 22(6):738. PubMed ID: 12556085
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, dialysate losses, and serum lipids during continuous ambulatory peritoneal dialysis.
    Rubin J; Walsh D; Bower JD
    Am J Kidney Dis; 1987 Aug; 10(2):104-8. PubMed ID: 3605088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is peritoneal dialysis a good option for black patients?
    Raj DS; Roscoe J; Manuel A; Abreo K; Dominic SS; Work J
    Am J Kidney Dis; 1999 Feb; 33(2):325-33. PubMed ID: 10023646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis.
    De Vecchi AF; Catena FB; Accinni R; Patrosso C
    Kidney Int; 1999 Oct; 56(4):1604-5. PubMed ID: 10610417
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid abnormalities in black renal patients.
    Burrell DE; Antignani A; Goldwasser P; Mittman N; Fein PA; Slater PA; Gan A; Avram MM
    N Y State J Med; 1991 May; 91(5):192-6. PubMed ID: 1857570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.